髓状细胞MHC I表达驱动CD8+ T细胞在非酒精性脂肪肝炎中的激活
Victoria R Adams1, Leonard B Collins2, Taufika Islam Williams2,3
1Department of Molecular and Structural Biochemistry, NC State University, Raleigh, NC, United States.
Frontiers in immunology
|January 26, 2024
概括
激活的CD8+ T细胞驱动非酒精性脂肪肝炎 (NASH) 纤维化和炎症. 骨髓细胞MHC I类表达,特别是H2Kb,对于这种激活至关重要,这表明NASH的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 激活的CD8+ T细胞有助于非酒精性脂肪肝炎 (NASH) 的发病,驱动炎症和纤维化.
- 在NASH中CD8+T细胞激活的机制,特别是抗原呈现,仍然不太清楚.
研究的目的:
- 研究MHC I类表达在CD8+T细胞激活中的作用及其对饮食诱导的NASH中纤维化和炎症的影响.
- 为了确定由MHC类I呈现的特定抗原,这些抗原有助于NASH病理.
主要方法:
- 利用了基因改造的小鼠模型,包括MHC I类淘汰 (MHC I KO),Kb转基因和骨髓细胞特异的Kb淘汰 (LysM Kb KO) 的小鼠.
- 使用流细胞计,基因表达分析和组织学评估肝炎和纤维化.
- 通过质谱分析分析了肝脏I类免疫体.
主要成果:
- 在NASH期间,MHC I类,特别是H2Kb在髓状细胞中被上调.
- MHC I KO小鼠对NASH诱导的炎症和纤维化有保护作用.
- 由H2Kb呈现的新型NASH相关,Ncf2,激活了CD8+ T细胞.
- NADPH氧化酶活性与Ncf2生成有关.
结论:
- 骨髓细胞MHC I类表达对于CD8+ T细胞驱动的炎症和饮食诱导的NASH中的纤维化至关重要.
- Ncf2是理解和治疗NASH的潜在目标.
- NADPH氧化酶可能在产生NASH特异性抗原中发挥作用.
相关概念视频
T Cell Activation and Clonal Selection
735
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
735
Antigens Involved in Adaptive Immunity
496
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
496
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K


